DNAJC18 (DnaJ Heat Shock Protein Family Member C18) is a member of the DnaJ/Hsp40 family of molecular chaperones. While initially characterized as a天王 gene with predicted chaperone activity, emerging research suggests potential roles in protein folding, quality control, and cellular stress responses that may be relevant to neurodegenerative disease pathogenesis.
| Property | Value |
|---|---|
| Gene Symbol | DNAJC18 |
| Gene Name | DnaJ Heat Shock Protein Family Member C18 |
| Chromosomal Location | 4q22.1 |
| NCBI Gene ID | 54962 |
| OMIM | 610091 |
| UniProt | Q9H7E4 |
| Aliases | DNAJD, JM24 |
| Gene Type | Protein coding |
| Transcript Length | 1,362 bp (coding sequence) |
DNAJC18 contains several key structural domains characteristic of DnaJ family proteins:
DNAJC18 participates in several cellular processes:
DNAJC18 exhibits broad but variable expression across tissues:
Within the central nervous system, DNAJC18 expression has been detected in:
The expression in substantia nigra is particularly notable given its relevance to Parkinson's disease pathogenesis.
While direct evidence for DNAJC18 in neurodegenerative diseases remains limited, several mechanistic links suggest potential involvement:
The unfolded protein response (UPR) and protein aggregation are central features of neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. As a molecular chaperone, DNAJC18 may help mitigate protein aggregation, though its specific client proteins in neurons remain characterized.
The endoplasmic reticulum (ER) is a major site of protein folding in secretory and membrane proteins. ER stress activates the UPR, which is implicated in neurodegeneration. DNAJC18, as a DnaJ protein involved in protein folding, may contribute to ER homeostasis.
Mitochondrial dysfunction is a hallmark of neurodegeneration. Some DnaJ proteins localize to mitochondria and assist in protein import and quality control. Further research is needed to determine if DNAJC18 has similar mitochondrial functions.
Currently, there are no direct therapeutic targets involving DNAJC18. However, enhancing cellular protein homeostasis capacity—including chaperone systems—has been explored as a therapeutic strategy for neurodegenerative diseases. Understanding DNAJC18's specific functions may reveal:
Based on homology to other DnaJ proteins, DNAJC18 likely interacts with:
While specific pathogenic mutations in DNAJC18 have not been firmly established as causes of neurodegeneration, the gene is located in a chromosomal region (4q22.1) that warrants investigation for potential links to neurological disorders.
Key questions remain about DNAJC18: